Cancer
« Previous EntriesNew Women, Smoking, And Heart Disease: Toenails Tell The Tale
Monday, October 6th, 2008In a first-of-its-kind study, research results show that toenail nicotine levels can help predict risk of coronary heart disease (CHD) in women. Researchers at University of California, San Diego, School of Medicine, in collaboration with colleagues from Harvard University, showed that the higher the level of nicotine in the toenails, the higher the risk of […]
Topic Cancer Risk Soars In Hiv-infected People: Study (reuters)
Sunday, October 5th, 2008Reuters - People with HIV have a much higher risk for many cancers, including anal cancer, but a lower risk for prostate cancer, researchers said on Tuesday. (Link)
This entry was important to me:
These icons link to social bookmarking sites where readers can share and discover new web pages.
Update Brachytherapy Vs. Cryoablation In The Treatment Of Prostate Cancer
Sunday, October 5th, 2008UroToday.com - Both cryoablation and brachytherapy are well studied alternatives to radical prostatectomy. The techniques are similar in the application of the needles to deliver the treatment, planning software and algorithms to achieve the best coverage, are delivered as outpatient treatment, and efficacy. The techniques differ in that cryoablation can be utilized for radiation failures […]
Current Initial Colonoscopy Key To Cancer Detection (healthday)
Saturday, October 4th, 2008A first-time colonoscopy to remove precancerous polyps plays a bigger role in reducing the risk of dying from colon cancer than do follow-up screenings done years later, a new study suggests. (Link)
This entry was important to me:
These icons link to social bookmarking sites where readers can share and discover new web pages.
Comments Requested Sound Pharmaceuticals Files Second Ind With The Fda For The Prevention Of Chemotherapy Induced Hearing Loss In Advanced Stage Cancer
Saturday, October 4th, 2008Sound Pharmaceuticals (SPI) has filed an Investigational New Drug Application with the FDA for the clinical testing of a proprietary formulation of ebselen for the prevention of chemotherapy induced hearing loss or ototoxicity. The oral capsule containing ebselen, SPI-3005, will be tested in advanced stage lung cancer […]
Join The Fight Against Cancer Radiation, Chemo Costs Drive Cancer Spending In U.s. (reuters)
Friday, October 3rd, 2008Today, Reuters - The cost of treating cancer has soared in the United States as more chemotherapy and radiation treatments become available to more patients, researchers reported on Tuesday. (Link)
This entry was important to me:
These icons link to social bookmarking sites where readers can share and discover new web pages.
Updated New Cyberknife Technologies Demonstrate Dramatic Reduction In Treatment Times
Friday, October 3rd, 2008Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced that the first patients were treated using the next generation CyberKnife(R) Robotic Radiosurgery System that was recently installed at the Oklahoma CyberKnife, LLC in Tulsa, OK. (Link)
This entry was important to me:
These icons link […]
Important First Anniversary Of England’s Smokefree Law Shows Public Ready To Accept Even Stronger Tobacco Control Measures
Thursday, October 2nd, 2008First Anniversary of England’s smokefree law shows public ready to accept even stronger tobacco control measures On the first anniversary of England’s smokefree law, public support for smokefree environments is still rising [1] and surveys show that most people are in favour of even stronger measures to reduce smoking and to […]
Comments Requested Sunlight Helps Put Lung Cancer In The Shade (healthday)
Thursday, October 2nd, 2008HealthDay - MONDAY, Dec. 17 (HealthDay News) — Something as common andavailable as sunlight may help prevent some lung cancers, researcherssay. (Link)
This entry was important to me:
These icons link to social bookmarking sites where readers can share and discover new web pages.
Subject Allos Therapeutics Initiates Phase 2b Study Of Pdx In Patients With Non-small Cell Lung Cancer
Wednesday, October 1st, 2008Admin wrote: Allos Therapeutics, Inc. (Nasdaq: ALTH) announced the initiation of patient enrollment in a Phase 2b, randomized, multi-center study comparing PDX (pralatrexate) and Tarceva (R) (erlotinib) in patients with Stage IIIB/IV non-small cell lung cancer (NSCLC) who are, or have been, cigarette smokers who have failed treatment with at least one prior platinum-based chemotherapy regimen. […]